Recombinant Escherichia coli O17:K52:H18 Peptide chain release factor 1 (prfA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipment, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
prfA; ECUMN_1508; Peptide chain release factor 1; RF-1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-360
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli O17:K52:H18 (strain UMN026 / ExPEC)
Target Names
prfA
Target Protein Sequence
MKPSIVAKLE ALHERHEEVQ ALLGDAQTIA DQERFRALSR EYAQLSDVSR CFTDWQQVQE DIETAQMMLD DPEMREMAQD ELREAKEKSE QLEQQLQVLL LPKDPDDERN AFLEVRAGTG GDEAALFAGD LFRMYSRYAE ARRWRVEIMS ASEGEHGGYK EIIAKISGDG VYGRLKFESG GHRVQRVPAT ESQGRIHTSA CTVAVMPELP DAELPDINPA DLRIDTFRSS GAGGQHVNTT DSAIRITHLP TGIVVECQDE RSQHKNKAKA LSVLGARIHA AEMAKRQQAE ASTRRNLLGS GDRSDRNRTY NFPQGRVTDH RINLTLYRLD EVMEGKLDML IEPIIQEHQA DQLAALSEQE
Uniprot No.

Target Background

Function
Peptide chain release factor 1 terminates translation in response to the stop codons UAG and UAA.
Database Links
Protein Families
Prokaryotic/mitochondrial release factor family
Subcellular Location
Cytoplasm.

Q&A

What is the biological function of peptide chain release factor 1 (prfA) in E. coli?

Peptide chain release factor 1 (prfA) plays a critical role in translation termination during protein synthesis in E. coli. It specifically recognizes the stop codons UAA and UAG in the mRNA and catalyzes the hydrolysis of the peptidyl-tRNA bond, resulting in the release of the newly synthesized polypeptide from the ribosome.

Methodological approach: To investigate prfA function in E. coli, researchers should consider combining genetic approaches (gene knockout/complementation) with in vitro translation assays using purified components. Ribosome profiling can provide genome-wide insights into translation termination events mediated by prfA.

How does prfA structure relate to its function in protein synthesis?

The structure of prfA is highly specialized for its role in translation termination. While specific structural data for E. coli O17:K52:H18 prfA is not detailed in the available literature, research on release factors in bacteria indicates several key structural features:

  • A domain responsible for stop codon recognition

  • A catalytic domain containing the GGQ motif essential for peptidyl-tRNA hydrolysis

  • Domains that interact with the ribosomal A site

Research on surface charge distribution in PrfA proteins suggests that positive charges in binding pockets play significant roles in protein function . This electrostatic property likely influences interactions with ribosomal RNA and the positioning of the catalytic center.

Methodological approach: X-ray crystallography or cryo-electron microscopy of prfA-ribosome complexes can provide detailed structural insights. Site-directed mutagenesis targeting conserved residues can help correlate structure with function.

What expression systems are suitable for producing recombinant E. coli prfA?

Recombinant prfA can be produced using various expression systems, each with distinct advantages for different research applications:

Table 1: Expression Systems for Recombinant prfA Production

Expression SystemAdvantagesDisadvantagesBest Applications
E. coliHigh yield, economical, rapid growthPotential for inclusion bodiesStructural studies, antibody production
YeastPost-translational modifications, proper foldingLower yield than E. coliFunctional studies requiring eukaryotic processing
BaculovirusHigh-level expression, complex proteinsTechnical complexity, time-consumingLarge-scale production of properly folded protein
Mammalian cellsNative-like processingHighest cost, lowest yieldStudies requiring mammalian-specific modifications

Based on available information on recombinant protein production, E. coli, yeast, baculovirus, or mammalian cell systems are all viable options for prfA expression . The choice depends on specific research requirements, particularly regarding protein folding and post-translational modifications.

Methodological approach: When developing an expression system, optimize codon usage for the host organism, consider adding purification tags that won't interfere with function, and validate the recombinant protein's activity through functional assays.

How can researchers verify the functionality of recombinant prfA?

Confirming that recombinant prfA retains its native functionality is essential before proceeding with advanced studies. Several methods can be employed:

  • In vitro translation termination assays: Using defined templates containing UAA or UAG stop codons to measure peptide release efficiency

  • Complementation studies: Testing whether the recombinant protein can rescue growth defects in prfA-deficient strains

  • Ribosome binding assays: Assessing the protein's ability to interact with ribosomes in the presence of stop codons

  • Stop codon readthrough reporters: Using reporter constructs with premature stop codons to quantify termination efficiency

Methodological approach: A multi-method validation approach provides the most robust confirmation of functionality. Compare activity parameters of the recombinant protein with native prfA to ensure equivalence.

How does the regulation of prfA expression differ between pathogenic and non-pathogenic bacteria?

Regulatory mechanisms for prfA vary significantly between bacterial species, particularly when comparing pathogenic bacteria like Listeria monocytogenes with non-pathogenic E. coli strains:

In Listeria monocytogenes, PrfA functions as a master virulence regulator with a distinct ON/OFF switch. PrfA-regulated genes are activated inside host cells (PrfA "ON") but repressed in environmental conditions (PrfA "OFF") . This regulatory mechanism balances the fitness costs associated with expressing virulence factors when they're not needed.

Research has demonstrated that constitutive activation of the PrfA regulon (using a PrfA* mutant locked in the "ON" state) significantly impairs Listeria growth in both laboratory media and soil environments . Specifically:

  • Growth rate (μ) is reduced in rich medium

  • Maximum growth (A) is decreased in standard culture conditions

  • Performance in soil microcosms is strongly impaired

  • No fitness disadvantage is observed in infected cells where virulence factors are beneficial

In contrast, E. coli prfA primarily serves the fundamental cellular function of translation termination and likely exhibits different regulatory patterns focused on maintaining appropriate levels for protein synthesis rather than virulence regulation.

Methodological approach: Comparative transcriptomics and proteomics of prfA expression under various environmental conditions can elucidate regulatory mechanisms. Reporter constructs with the prfA promoter region can identify specific regulatory elements.

What experimental design approaches are optimal for studying prfA function?

Designing rigorous experiments to investigate prfA function requires careful consideration of statistical power, variables, and appropriate controls. Based on optimal experimental design principles described in research methodology literature , several approaches are particularly valuable:

  • Sequential approach: Begin with preliminary experiments to establish baseline parameters, then refine subsequent experiments based on initial findings.

  • D-optimality criterion: Design experiments to maximize the statistical information about the full set of model parameters rather than focusing on a single parameter .

  • Response optimization: For complex models with interaction terms, the optimal design requires a probability split that balances responses across experimental conditions .

For studying prfA specifically, researchers should consider:

Table 2: Experimental Design Considerations for prfA Studies

Study ObjectiveDesign ApproachKey VariablesStatistical Considerations
Structure-function relationshipSite-directed mutagenesisAmino acid substitutions, functional domainsMultiple testing correction, effect size estimation
Regulation mechanismsTime-course experimentsEnvironmental conditions, growth phasesTime-series analysis, appropriate sampling intervals
Interaction partnersAffinity purification, crosslinkingBuffer conditions, crosslinker chemistryFalse discovery rate control, confirmation assays
In vivo functionGene replacement, complementationExpression levels, genetic backgroundAppropriate controls, replication number

Methodological approach: For main-effects models, assign most variables two levels (upper and lower bounds) and allocate these across experiments according to standard design arrays . For models with interaction terms, more complex designs may be required.

How does surface charge distribution affect prfA function and activation?

The electrostatic properties of prfA play a critical role in its interactions with the ribosome and substrate recognition. Research on PrfA in Listeria indicates that positive charge in the binding pocket contributes significantly to protein function .

While detailed information specific to E. coli O17:K52:H18 prfA is limited in the available literature, we can infer that charge distribution likely influences:

  • Ribosome binding affinity

  • Stop codon recognition specificity

  • Conformational changes during catalysis

  • Interactions with other translation factors

Methodological approach: Combine computational approaches (electrostatic surface mapping, molecular dynamics simulations) with experimental validation through charge-altering mutations. Measure effects on binding kinetics and catalytic efficiency across pH ranges to assess charge-dependent functionality.

What are the fitness costs associated with altered prfA expression or function?

Understanding the fitness implications of prfA modification is crucial for both basic research and potential applications. Research on PrfA in Listeria provides valuable insights into how altering translation termination factors can affect bacterial physiology.

In Listeria monocytogenes, constitutive activation of PrfA imposes significant fitness costs in environments where virulence factors are unnecessary. Specifically:

  • Growth rate (μ) and maximum growth (A) are reduced in rich medium

  • Performance in soil microcosms is significantly impaired

  • The growth disadvantage is specifically due to unnecessary expression of virulence determinants rather than pleiotropic regulatory effects

For E. coli prfA, the fitness implications would differ but might include:

Methodological approach: Combine growth rate analyses, competition assays, and global approaches (transcriptomics, proteomics, metabolomics) to comprehensively assess fitness effects. Design experiments with appropriate controls to isolate specific effects of prfA modification.

How can researchers optimize experimental design when investigating prfA interactions with other translation factors?

Studying interactions between prfA and other components of the translation machinery requires sophisticated experimental design approaches. Based on optimal experimental design principles , researchers should consider:

  • Factor selection: Identify the most influential factors for optimization rather than testing all possible variables

  • Response variables: Define clear, quantifiable outcomes that directly measure interaction quality or strength

  • Design efficiency: For main-effects models, standard main-effects designs are appropriate; for interactive models, full factorial design arrays may be required

  • Sequential refinement: Begin with broad screening experiments, then focus on promising interaction parameters for detailed characterization

Table 3: Optimization Approaches for prfA Interaction Studies

Interaction Study TypeOptimal Design ApproachResponse VariablesStatistical Considerations
Ribosome bindingThree-level designs for quadratic termsBinding affinity (Kd), association/dissociation ratesResponse surface methodology
Release factor cooperationFull factorial designTermination efficiency, kinetic parametersAnalysis of interaction effects
Regulatory interactionsMain-effects design with two-level factorsExpression levels, activity modulationOptimal probability split (.82/.18 for two-variable model)

Methodological approach: For interactive models, use the full set of attribute permutations (full factorial design). The optimal probability split for fully specified interactive models is consistently .82/.18, regardless of attribute number . This statistical insight can guide experimental design to maximize information from limited samples.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.